Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Do 100 kiloDaltons matter? Plasma volume effects of Gelofusine vs Voluven during laparoscopic cholecystectomy
2008-005135-15Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cholelithiasis comparing Gelofusine arm with Voluven arm (2 arms). Primary endpoints: Plasma volume expansion magnitude and duration, Changes in haematocrit and 4 more. Started Jan 2009; status: completed.
02
Drugs
gelatinVolulyte
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on 2008-005135-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005135-15.